UNIFLASH

Serial Number 86361429
606

Registration Progress

Application Filed
Aug 8, 2014
Under Examination
Jun 9, 2015
Approved for Publication
Apr 14, 2015
Published for Opposition
Apr 14, 2015
Registered

Basic Information

Serial Number
86361429
Filing Date
August 8, 2014
Published for Opposition
April 14, 2015
Abandonment Date
January 11, 2016
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jan 11, 2016
Classes
005 010 042

Rights Holder

UNITHER PHARMACEUTICALS

99
Address
Espace industriel Nord, CS 28028
151 Rue André Durouchez
80084 AMIENS
FR

Ownership History

UNITHER PHARMACEUTICALS

Original Applicant
99
80084 AMIENS FR

UNITHER PHARMACEUTICALS

Owner at Publication
99
80084 AMIENS FR

Legal Representation

Attorney
Andrew J. Patch
USPTO Deadlines 2 active 2 overdue
Deadline Type Event Code Deadline Date Days Until Priority Extension Available
OPPOSITION
Notice of Publication
NPUB May 14, 2015 3707 days overdue Medium Until Jun 14, 2015
ITU SOU
Notice of Allowance Mailed - SOU Required
NOAM Dec 09, 2015 3498 days overdue High Until Jun 09, 2016

Application History

23 events
Date Code Type Description
Jan 11, 2016 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Jan 11, 2016 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Sep 11, 2015 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 11, 2015 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 4, 2015 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jun 9, 2015 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 14, 2015 PUBO A PUBLISHED FOR OPPOSITION
Apr 14, 2015 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 25, 2015 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 7, 2015 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 4, 2015 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 10, 2015 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 10, 2015 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 10, 2015 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 24, 2014 CNRT R NON-FINAL ACTION WRITTEN
Nov 24, 2014 GNRT F NON-FINAL ACTION E-MAILED
Nov 24, 2014 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 22, 2014 DOCK D ASSIGNED TO EXAMINER
Sep 22, 2014 AMPX O PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Sep 15, 2014 ALIE A ASSIGNED TO LIE
Sep 11, 2014 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED
Aug 19, 2014 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 12, 2014 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Liquid pharmaceutical preparations for perlingual administration for the treatment of cough and cold, heartburn, cardiovascular disease, bowel disorder, constipation, diarrhea, pain and inflammation, headaches and cephalalgia, allergy, asthma bronchitis and chronic obstructive pulmonary disease, neurological disorder; pharmaceutical preparations being administered in order to achieve a rapid effect after administration for the treatment of cough and cold, heartburn, cardiovascular disease, bowel disorder, constipation, diarrhea, pain and inflammation, headaches and cephalalgia, allergy, asthma bronchitis and chronic obstructive pulmonary disease, neurological disorder; migraine preparations; alkaloids for medical purposes; medicinal alcohol; medical preparations for slimming purposes; analgesics; anti­ asthma preparations; antiparasitic preparations; antiseptic preparations; med icated mouth wash; medicinal oils; tranquilizers; siccative drying agents for medical purposes; single-dose capsules sold empty for pharmaceutical preparations for medical purposes
First Use Anywhere: 0
First Use in Commerce: 0
Class 010
Pharmaceutical flasks for medical use; single-dose packaging for pharmaceutical aerosols; spray bottles sold empty for pharmaceuticals for medical use; metering bottles for pharmaceuticals for medical purposes
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
Research and development of packaging containers for pharmaceutical preparations for medical use; research and development of single-dose packaging containers; research and development of flexible single-dose packaging containers; research and development of medical products having a rapid effect after administration; research and development of medical products for perlingual administration and having a rapid effect after being taken
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005 010 042